Congleton Jon

Congleton Jon is listed in filings as Chief Executive Officer at Mineralys Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 15, 2026, including sale activity. Recent filings connect the profile to Mineralys Therapeutics, Inc. (MLYS). The current snapshot covers public activity from Nov 24, 2025 to Apr 15, 2026. Reported amounts are shown as $13.0K to $293.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.